Experienced in Prostate Cancer

Wei S. Chua

Corner Of Goulburn And Elizabeth Streets, 
Liverpool, NSW, AU 
Experienced in Prostate Cancer
Corner Of Goulburn And Elizabeth Streets, 
Liverpool, NSW, AU 
OverviewLocationsClinical Research

Overview

Wei Chua practices in Liverpool, Australia. Chua is rated as an Experienced expert by MediFind in the treatment of Prostate Cancer. Their top areas of expertise are Colorectal Cancer, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC), Chronic Erosive Gastritis, and Tissue Biopsy.

Their clinical research consists of co-authoring 71 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 12 articles and participated in 1 clinical trial in the study of Prostate Cancer.

Locations

Corner Of Goulburn And Elizabeth Streets, Liverpool, NSW 2170, Australia
Other Locations
Hospital Road, Concord, NSW 2139, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 27, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial Comparing CB-839 in Combination With Cabozantinib (CB-Cabo) vs. Placebo With Cabozantinib (Pbo-Cabo) in Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC)
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial Comparing CB-839 in Combination With Cabozantinib (CB-Cabo) vs. Placebo With Cabozantinib (Pbo-Cabo) in Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC)
Enrollment Status: Completed
Publish Date: March 20, 2023
Intervention Type: Drug
Study Drugs: CB-839, Cabozantinib
Study Phase: Phase 2
Coronavirus Outcomes Registries in Immunocompromised Individuals Australia (CORIA): a Multisite Registry and Optional Biorepository in People With COVID-19 and Selected Conditions Affecting Immune Function
Coronavirus Outcomes Registries in Immunocompromised Individuals Australia (CORIA): a Multisite Registry and Optional Biorepository in People With COVID-19 and Selected Conditions Affecting Immune Function
Enrollment Status: Unknown
Publish Date: September 01, 2021
View 2 Less Clinical Trials

71 Total Publications

Application of Generative Artificial Intelligence for Physician and Patient Oncology Letters-AI-OncLetters.
Application of Generative Artificial Intelligence for Physician and Patient Oncology Letters-AI-OncLetters.
Journal: JCO clinical cancer informatics
Published: May 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Chua's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile